Abstract
Chronic Inflammatory Response Syndrome (CIRS) is a complex, multi-system condition associated with persistent inflammation in response to biotoxins like mould or other environmental triggers. Mitochondrial dysfunction has been implicated in the pathophysiology of CIRS, contributing to chronic inflammation and exacerbating symptoms. Pyrroloquinoline quinone (PQQ), a redox cofactor, has gained attention for its potential neuroprotective, anti-inflammatory, and mitochondria-supporting properties. Additionally, CIRS shares overlapping features with cytokine storm effects observed in COVID infection, long COVID, and potential inflammatory reactions related to mRNA vaccine administration. This letter explores the role of PQQ in managing CIRS and addressing mitochondrial dysfunction caused by multiple potential triggers. However, further research is needed to confirm the effectiveness and safety of PQQ in addressing CIRS and related conditions.
Subject
General Materials Science
Reference60 articles.
1. Hamilton D. Understanding mycotoxin-induced illness: part 1. Altern Ther Health Med. 2022;28(5):8-11 .
2. Exposure to Actinobacteria resident in water-damaged buildings and resultant immune injury in Chronic Inflammatory Response Syndrome;Shoemaker;Med Res Archives,2021
3. Inhalational Alzheimer's disease: an unrecognized- and treatable- epidemic;Bredesen;Aging (Albany NY),2016
4. Thomson DR. Chronic inflammatory response syndrome acquired after exposure to water- damaged buildings (CIRS-WDB). 2013:1-9.
5. Report on the Inquiry into Biotoxin-related Illnesses in Australia. Commonwealth Parliament; Parliament House. 2018.